See also this year's filing and all EDGAR filings for this company.
PDF Report 0000919722_2012_Astex_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0000919722, Astex Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 136,570,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 130,992,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,013,000 |
| 3 | remainder_Assets | 2,373,000 |
| 4 | LiabilitiesCurrent | 34,670,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 22,277,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,842,000 |
| 9 | ResearchAndDevelopmentExpense | 43,895,000 |
| 10 | remainder_Expenses | 861,000 |
| 11 | remainder_Revenues | 66,914,000 |
| 12 | remainder_NetIncome | 226,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 276,948,000 |
| 1 | Liabilities | 56,947,000 |
| 2 | Expenses | 61,598,000 |
| 3 | Revenues | 66,914,000 |
| 4 | StockholdersEquity | 220,001,000 |
| 5 | NetIncome | 5,542,000 |
| 6 | ComprehensiveNetIncome | 5,542,000 |
| 7 | BaseVar | 231,316,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.91 |
| 9 | EconomicCapitalRatio | 3.62 |
Edgar->Model Mapping
Feature Distribution
